These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 38518551)
1. Upping the ante: enhanced expression of interferon-antagonizing ORF6 and ORF9b proteins by SARS-CoV-2 variants of concern. Caobi A; Saeed M Curr Opin Microbiol; 2024 Jun; 79():102454. PubMed ID: 38518551 [TBL] [Abstract][Full Text] [Related]
2. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis. Kehrer T; Cupic A; Ye C; Yildiz S; Bouhaddou M; Crossland NA; Barrall EA; Cohen P; Tseng A; Çağatay T; Rathnasinghe R; Flores D; Jangra S; Alam F; Mena I; Aslam S; Saqi A; Rutkowska M; Ummadi MR; Pisanelli G; Richardson RB; Veit EC; Fabius JM; Soucheray M; Polacco BJ; Ak B; Marin A; Evans MJ; Swaney DL; Gonzalez-Reiche AS; Sordillo EM; van Bakel H; Simon V; Zuliani-Alvarez L; Fontoura BMA; Rosenberg BR; Krogan NJ; Martinez-Sobrido L; García-Sastre A; Miorin L Cell Host Microbe; 2023 Oct; 31(10):1668-1684.e12. PubMed ID: 37738983 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways. Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550 [TBL] [Abstract][Full Text] [Related]
4. Evolution of enhanced innate immune evasion by SARS-CoV-2. Thorne LG; Bouhaddou M; Reuschl AK; Zuliani-Alvarez L; Polacco B; Pelin A; Batra J; Whelan MVX; Hosmillo M; Fossati A; Ragazzini R; Jungreis I; Ummadi M; Rojc A; Turner J; Bischof ML; Obernier K; Braberg H; Soucheray M; Richards A; Chen KH; Harjai B; Memon D; Hiatt J; Rosales R; McGovern BL; Jahun A; Fabius JM; White K; Goodfellow IG; Takeuchi Y; Bonfanti P; Shokat K; Jura N; Verba K; Noursadeghi M; Beltrao P; Kellis M; Swaney DL; García-Sastre A; Jolly C; Towers GJ; Krogan NJ Nature; 2022 Feb; 602(7897):487-495. PubMed ID: 34942634 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Yuen CK; Lam JY; Wong WM; Mak LF; Wang X; Chu H; Cai JP; Jin DY; To KK; Chan JF; Yuen KY; Kok KH Emerg Microbes Infect; 2020 Dec; 9(1):1418-1428. PubMed ID: 32529952 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection. Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442 [TBL] [Abstract][Full Text] [Related]
12. Type I and III interferon responses in SARS-CoV-2 infection. Kim YM; Shin EC Exp Mol Med; 2021 May; 53(5):750-760. PubMed ID: 33953323 [TBL] [Abstract][Full Text] [Related]
13. The Deubiquitinase USP29 Promotes SARS-CoV-2 Virulence by Preventing Proteasome Degradation of ORF9b. Gao W; Wang L; Ju X; Zhao S; Li Z; Su M; Xu J; Wang P; Ding Q; Lv G; Zhang W mBio; 2022 Jun; 13(3):e0130022. PubMed ID: 35638730 [TBL] [Abstract][Full Text] [Related]
16. A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication. Zhou Y; Chen Z; Liu S; Liu S; Liao Y; Du A; Dong Z; Zhang Y; Chen X; Tao S; Wu X; Razzaq A; Xu G; Tan DA; Li S; Deng Y; Peng J; Dai S; Deng X; Zhang X; Jiang T; Zhang Z; Cheng G; Zhao J; Xia Z Signal Transduct Target Ther; 2024 Jun; 9(1):159. PubMed ID: 38937432 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98. Addetia A; Lieberman NAP; Phung Q; Hsiang TY; Xie H; Roychoudhury P; Shrestha L; Loprieno MA; Huang ML; Gale M; Jerome KR; Greninger AL mBio; 2021 Apr; 12(2):. PubMed ID: 33849972 [TBL] [Abstract][Full Text] [Related]
18. Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b. Yu M; Li J; Gao W; Li Z; Zhang W J Virol; 2024 Jun; 98(6):e0162423. PubMed ID: 38709105 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells. Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952 [TBL] [Abstract][Full Text] [Related]
20. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics. Cheemarla NR; Watkins TA; Mihaylova VT; Wang B; Zhao D; Wang G; Landry ML; Foxman EF J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34128960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]